Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1990 1
2015 1
2016 1
2018 1
2020 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

5 results

Results by year

Filters applied: . Clear all
Page 1
Biology and treatment of metastasis of sarcoma to the brain.
Ahmad O, Chan M, Savage P, Watabe K, Lo HW, Qasem S. Ahmad O, et al. Front Biosci (Elite Ed). 2016 Jan 1;8(2):233-44. doi: 10.2741/E764. Front Biosci (Elite Ed). 2016. PMID: 26709659 Free article. Review.
In addition, MicroRNAs have been shown to have either positive or negative impact on sarcoma biology and metastasis. Sarcoma is considered one of the classic radio- and chemo-resistant brain metastasis, hence the use of multiple modalities in order to improve …
In addition, MicroRNAs have been shown to have either positive or negative impact on sarcoma biology and metastasis. Sarcoma i …
Development of a disease-specific graded prognostic assessment index for the management of sarcoma patients with brain metastases (Sarcoma-GPA).
Patrikidou A, Chaigneau L, Isambert N, Kitikidou K, Shanley R, Ray-Coquard I, Valentin T, Malivoir B, Laigre M, Bay JO, Moureau-Zabotto L, Bompas E, Piperno-Neumann S, Penel N, Alcindor T, Guillemet C, Duffaud F, Hügli A, Le Pechoux C, Dhermain F, Blay JY, Sperduto PW, Le Cesne A. Patrikidou A, et al. BMC Cancer. 2020 Feb 12;20(1):117. doi: 10.1186/s12885-020-6548-6. BMC Cancer. 2020. PMID: 32050939 Free PMC article.
Thus far, a prognostic index to direct treatment decisions is lacking for adult sarcoma patients with brain metastases. METHODS: We performed a multicentre analysis of a national group of expert sarcoma tertiary centres (French Sarcoma Group, GSF-GETO) …
Thus far, a prognostic index to direct treatment decisions is lacking for adult sarcoma patients with brain metastases. METHOD …
Brain Metastases from Adult Sarcoma: Prognostic Factors and Impact of Treatment. A Retrospective Analysis from the French Sarcoma Group (GSF/GETO).
Chaigneau L, Patrikidou A, Ray-Coquard I, Valentin T, Linassier C, Bay JO, Moureau Zabotto L, Bompas E, Piperno-Neumann S, Penel N, Alcindor T, Laigre M, Guillemet C, Salas S, Hugli A, Domont J, Sunyach MP, Lecesne A, Blay JY, Nerich V, Isambert N. Chaigneau L, et al. Oncologist. 2018 Aug;23(8):948-955. doi: 10.1634/theoncologist.2017-0136. Epub 2018 Jun 22. Oncologist. 2018. PMID: 29934413 Free PMC article.
A prognostic index is important to guide both clinical decision-making and outcomes research, but one such is lacking for adult sarcoma patients with brain metastases. The current study describes brain metastasis in a large cohort of sarcoma patients. …
A prognostic index is important to guide both clinical decision-making and outcomes research, but one such is lacking for adult sarcoma …
Assessment of uncertainties in radiation-induced cancer risk predictions at clinically relevant doses.
Nguyen J, Moteabbed M, Paganetti H. Nguyen J, et al. Med Phys. 2015 Jan;42(1):81-9. doi: 10.1118/1.4903272. Med Phys. 2015. PMID: 25563249 Free PMC article.
PURPOSE: Theoretical dose-response models offer the possibility to assess second cancer induction risks after external beam therapy. The parameters used in these models are determined with limited data from epidemiological studies. ...In the studied cases, the patient aver …
PURPOSE: Theoretical dose-response models offer the possibility to assess second cancer induction risks after external beam therapy. …
Advances and management of solid tumors in children.
Nesbit ME Jr. Nesbit ME Jr. Cancer. 1990 Feb 1;65(3 Suppl):696-702. doi: 10.1002/1097-0142(19900201)65:3+<696::aid-cncr2820651313>3.0.co;2-t. Cancer. 1990. PMID: 2154315 Review.
With Wilms' tumor, the survival rate has risen to 80%, but a subset of these patients with unfavorable histologies and therefore a higher rate of relapse need a different strategy. For those patients with soft tissue sarcoma, brain tumors, and bone tumors the combin …
With Wilms' tumor, the survival rate has risen to 80%, but a subset of these patients with unfavorable histologies and therefore a higher ra …